Clinical-stage pharmaceutical Incannex Healthcare Ltd. (Nasdaq: IXHL) is moving forward with a new psychotherapy treatment program using psilocybin, the company announced Thursday. The Melbourne, Australia-based firm will ask the U.S. Food and Drug Administration for the green light to begin clinical trials in the U.S. for its Psi-GAD therapy. Its …
High Times Names 5th CEO in 5 Years
Despite a looming deadline with its lender ExWorks, High Times named Shaun Jarvis as interim chief executive officer. The financially troubled cannabis media company saw the departure of CEO Paul Henderson, who was also the interim chief financial officer and a director of Hightimes Holding Corp. on August 15. In …
TGOD Merger Boosts BZAM Q2 Revenues Amid Losses
BZAM Ltd. (OTC: BZAMF) reported its financial results ending June 30, showing rises in revenue but much higher losses. The company saw an 89% increase in gross revenues versus the second quarter last year, totaling $30 million. The company’s net revenues climbed to $19.3 million, marking a 66% growth from the …
Vermont Continues to Deliver Revenue for Slang
SLANG Worldwide Inc. (CNSX: SLNG) (OTCQB: SLGWF) reported revenue for the three months ended June 30 fell to $8.44 million versus last year’s $9.87 million for the same time period. All figures for the latest financial results are stated in Canadian dollars. Slang said that the revenue decline was primarily …